As a leader in cardiac cell therapy, Okyanos is very excited to bring this innovative treatment and new standard of care to patients in a near-shore, regulated jurisdiction. - Matt Feshbach, CEO Okyanos Adult stem cell therapy for heart disease has emerged as a new treatment alternative for those living with a poor quality of life as a result of severe coronary artery disease.
http://ift.tt/1xxQurf
http://ift.tt/1xxQurf
No comments:
Post a Comment